Impact of Proton Irradiation Depending on Breast Cancer Subtype in Patient-Derived Cell Lines
Marika Musielak,Kinga Graczyk,Małgorzata Liszka,Athanasia Christou,Monika A. Rosochowicz,Michał S. Lach,Beata Adamczyk,Wiktoria M. Suchorska,Tomasz Piotrowski,Bo Stenerlöw,Julian Malicki
DOI: https://doi.org/10.3390/ijms251910494
IF: 5.6
2024-09-30
International Journal of Molecular Sciences
Abstract:Research on different types of ionizing radiation's effects has been ongoing for years, revealing its efficacy in damaging cancer cells. Solid tumors comprise diverse cell types, each being able to respond differently to radiation. This study evaluated the radiobiological response of established (MDA-MB-231 (Triple negative breast cancer, TNBC), MCF-7 (Luminal A)) and patient-derived malignant cell lines, cancer-associated fibroblasts, and skin fibroblasts following proton IRR. All cell line types were irradiated with the proton dose of 2, 4, and 6 Gy. The radiobiological response was assessed using clonogenic assay, γH2AX, and p53 staining. It was noticeable that breast cancer lines of different molecular subtypes displayed no significant variations in their response to proton IRR. In terms of cancer-associated fibroblasts extracted from the tumor tissue, the line derived from a TNBC subtype tumor demonstrated higher resistance to ionizing radiation compared to lines isolated from luminal A tumors. Fibroblasts extracted from patients' skin responded identically to all doses of proton radiation. This study emphasizes that tumor response is not exclusively determined by the elimination of breast cancer cells, but also takes into account tumor microenvironmental variables and skin reactions.
biochemistry & molecular biology,chemistry, multidisciplinary